Figure 5. Immune infiltrate analysis and efficacy prediction of TALRGs signature. (A) The Wilcoxon test was applied to compare the proportions of immune cells between low- and high-risk groups. (B) Comparing the difference of the mRNA levels of immune checkpoints unpaired between the two risk groups using unpaired t-test. (C–J) Comparing the difference of IC50 value of chemotherapy drugs between the two risk groups using Wilcoxon test.